Immunohistochemical identification of stent-based ablation lesions in the superior vena cava and pulmonary veins by Vandecasteele, Tim et al.
 Special Section | Morphological bases of human diseases | Methodology                        Open Access
Immunohistochemical identification of stent-based
ablation lesions in the superior vena cava and pulmonary
veins
Tim Vandecasteele1*, Stijn Schauvliege2, Tim Boussy3, Matthew Philpott4, Eli Clement4, Lisse Vera5, Pieter Cornillie1,  
Ward De Spiegelaere1, Glenn Van Langenhove4, Gunther van Loon5 and Wim Van den Broeck1
Abstract
Background: Ablation procedures, in the context of atrial fibrillation treatment, induce lesions which are 
difficult to visualize in an acute phase. This study sought to develop an immunohistochemical technique 
to evaluate and visualize microscopically the applied acute ablation lesions, which may enable an objective 
assessment of the lesions as this is crucial to determine lesion transmurality.
Methods: In the present study, an ablation procedure was performed in vivo in six pigs at the level of the 
cranial vena cava and in-vitro at the level of the ostia of the pulmonary veins using the same custom-made 
stents and delivery system. The antibody myosin MYBPC3 was used to visualize indirectly the denaturation 
process induced by the heating procedure. Subsequently, the histological images were processed by using Fiji 
software to make standardized sections which are objectively comparable.
Results: In all samples, the ablation lesions were visualized immunohistochemically and clearly identified to 
enable lesion measurement. The absence of transmural lesions was noticed in the samples which were exposed 
to an insufficient or an extreme high energy level or in the case the myocardial layer was divided by an 
intermediate fat layer.
Conclusions: During postmortem histopathologic evaluation of ablated tissue, this technique offers a method 
to specifically determine the grade of muscle protein denaturation and to assess the degree of transmurality. 
Moreover, this study highlights the importance of myocardial tissue shielded by connective, fat and/
or charred tissue, from the penetrating ablation heat in the context of recurrence or persistence of atrial 
fibrillation.
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Introduction 
In men, atrial fibrillation (AF) is the most important cardiac 
arrhythmia with an increasing prevalence due to an ageing 
population [1,2]. Besides a medical treatment of AF, ablation 
of myocardial sleeve tissue is increasingly used [3]. AF is mainly 
caused by the elicitation of ectopic pulses from myocardial 
sleeve tissue and their conductance towards the heart [4]. Ab-
lation includes the interruption of the transfer of these pulses 
by using a heat or cold source. During an ablation procedure, 
lesions are applied to the myocardial tissue, especially at the 
level of the pulmonary veins wall or less commonly at the wall 
of the superior vena cava, coronary sinus or interatrial septum 
[5]. During evaluation of preclinical or clinical ablation trials, a 
distinct histological determination of the applied lesions, in an 
acute stage without the presence of repair connective tissue, 
remains difficult as regular histological staining of ablated tis-
sue fails to distinguish clearly denatured cells from intact cells. 
Consequently, an immunohistochemical technique might be 
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valuable to visualize and delineate precisely and objectively the 
ablated lesions and to evaluate the grade of lesion transmural-
ity. Transmural lesions can be the cornerstone for a successful 
ablation procedure as the use of the appropriate energy level 
will define the result of creating the required local lesion [6]. 
    However, during chronic follow-up studies based on bio-
psies or postmortem evaluation, ingrown connective tissue 
can be stained histologically to differentiate damaged from 
intact myocardial tissue. Different histological staining 
techniques for chronic lesions have been described, such as 
masson trichrome, hematoxylin and eosin, and elastic-van 
Gieson stains [6-9]. 
In this study, a technique is described to visualize and 
delineate immunohistochemically acute porcine ablation 
lesions at the level of the cranial vena cava (equivalent of the 
superior vena cava in humans) and at the level of the ostia 




Six 1.5 month old pigs (pigs 1-6, Table 1), weighing between 
40 and 45 kg were used in the animal trials performed at the 
IMMR institute, Paris, France according to the Ethical Com-
mittee approval number “Fulgur Medical 16-22”. Pigs were 
anesthetized using 6 mg/kg propofol and 2 % isoflurane. 
In each pig, one custom-made stent was placed inside the 
proximal part of the cranial vena cava. More specific, by using 
angiography the ablation ring of the stent was positioned to 
target myocardial tissue. Delivery of the stent through the right 
auricle was performed using a custom-made delivery catheter, 
followed by angiographic evaluation of the stent position. 
Pulmonary veins 
Fresh cardiopulmonary sets of nine pigs of 60 kg (pigs 7-12, 
Table 1) were used in the in-vitro trials performed at the 
Faculty of Veterinary Medicine, Ghent, Belgium. In each set, 
one custom-made stent was placed inside an ostium of the 
pulmonary veins and afterwards the stent and the surround-
ing tissue was excised from the cardiopulmonary set. 
Ablation procedure 
Superior vena cava 
The stent was heated wirelessly by placing the pig in a coil 
to induce a magnetic field between the stent and the coil as 
described by Vandecasteele et al. (2016) [10]. Each pig was 
treated with a different combination of stent diameter, abla-
tion time and power (Table 1). 
Pulmonary veins 
The sample was placed inside a closed water-perfused circuit 
and heated wirelessly, by placing a coil around the stent and 
the surrounding ostium, for different time periods, flow rate 
and with different power settings. 
Histology 
Superior vena cava
All pigs were euthanized directly after the ablation proce-






Implant size (mm) Remarks
Pig 1 150 - 0.190 280 - 0.210 150 - 0.225 21 No
circumferential
wall contact
Pig 2 210 - 0.195 150 - 0.210 -- 21 No
circumferential
wall contact
Pig 3 220 - 0.220 150 - 0.254 -- 24 --
Pig 4 60 - 0.282 -- -- 30 --
Pig 5 60 - 0.195 -- -- 30 --
Pig 6 210 - 0.207 60 - 0.254 -- 24 --
mT/kHz Duration (s) Flowrate (l/min) Implant size (mm) --
Pig 7 3.03/368 90 0 18 --
Pig 8 3/368 180 0 18 --
Pig 9 3/368 180 0 18 --
Pig 10 3/368 90 1.25 21 --
Pig 11 3/368 90 1.25 21 --
Pig 12 2.5/368 90 2 21 --
Pig 13 3/368 180 2 21 --
Pig 14 / / 0 18 --
Pig 15 / / 2 21 --
Table 1. Overview of the treatment strategies of the different pigs with indication of the ablation time 
(s), the applied power (W/mm2 or mT, kHz), flowrate (l/min) and stent size (mm).




dure. After removal of the heart-lung package, a part of the 
right auricle and the cranial vena cava, including the stent, 
were dissected. Hereafter, the stent was removed from the 
longitudinally opened blood vessel. The part of the vena 
cava demonstrating the burned marking of the stent was 
cut out and fixed in 4% formaldehyde solution for 24 hours. 
Subsequently, the samples were stored in alcohol 70%. Prior 
to the dehydration steps, the endothelial scar markings were 
stained with tissue ink (Figure 1). The dehydration procedure 
occurred according to standard laboratory procedures and, 
subsequently, the samples were embedded in paraffin us-
ing a Microm tissue processor STP 420D (Prosan, Merelbeke, 
Belgium) and Microm embedding station EC 350-1 (Prosan), 
respectively. Sections of 5 μm were cut longitudinally on a 
Microm H360 microtome (Prosan). 
Pulmonary veins 
The ablated tissue was removed from the stent and fixed, 
dehydrated, embedded and cut as described above. 
Immunohistochemistry 
The myocardial sleeve tissue of the cranial vena cava and the 
pulmonary veins of the different pigs was stained immuno-
histochemically with the polyclonal myosin marker MYBPC3 
(K-16: sc-50115; Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) to detect myosin-binding protein C (cardiac type), which 
is reactive with pig tissue and present in the myofibrils of 
cardiac and striated muscle tissue [11]. Immunostaining was 
performed using the Dako automated Autostainer Plus. No 
antigen retrieval was needed. Firstly, the sections were incu-
bated for 5 min with 3% hydrogen peroxide and 30 min with 
rabbit serum. After primary antibody incubation for 60 min, 
secondary antibody (rabbit/anti-goat, biotinylated, polyclonal, 
1:500; Dako, Glostrup, Denmark) was used for 30 min followed 
by streptavidin and horseradish peroxidase (streptavidin-HRP, 
1:1500, Dako) for 30 min. Visualization was performed with 
DAB (Dako) for 5 min. The immunohistochemical sections 
were observed under the light microscope (Olympus BX61, 
Olympus DP73 camera, Olympus, Belgium).
Indirect lesion identification is done as follows. The antibody 
MYBPC3 positive regions (dark staining) will refer to intact 
myocardial tissue whereas the ablated parts (lighter stain-
ing) will be negative for the immunohistochemical staining. 
Software processing 
Free software Fiji was used to process and to standardize the 
images of the immunohistochemical sections by using the 
same threshold for each section (Figure 2) [12]. After color 
deconvolution (for haematoxylin and DAB) and duplicating 
the image, the threshold was set at zero and 90. Afterwards, 
the adapted image was overlaid with the original image at 
50% opacity and flattened together. The scale bar was set 
and the images were measured. 
Results 
The Fiji processed images showed the lesions more clearly 
compared to the original images as demonstrated in Figure 2. 
A gradual change of brown shades was observed, depending 
on the position of the observed spot. If this spot is located 
close to the position of the applied heat source, a lighter zone 
is noticed compared to a spot located further away from the 
heat source (Figure 3). 
All immunohistochemical samples of the different pigs 
demonstrated clear ablation lesions, except of the two con-
trol samples (pigs 14 and 15, Table 1), which are visible on 
the sections as lighter zones compared to the non-ablated 
regions. These lighter zones also correspond with the tissue 
ink present at the endothelial side of the ablated region 
of the caudal vena cava sections. Some samples displayed 
transmural lesions (pigs 1, 2, 3, 4, 6, 8 and 13; Figures 2-4 
and 6) whereas other samples demonstrated no transmural 
lesions with lighter stained myosin-denaturation-patterns 
Figure 1. Ablated superior vena cava sample of pig 
1 with an applied endothelial ablation lesion, before 
(panel a) and after applying the blue tissue ink (panel b), 
scalebar=0.5cm.
Figure 2. Immunohistological image of an ablated superior 
vena cava of pig 1 with a transmural lesion before (left) and 
after (right) Fiji software processing. The ablation lesion is 
contoured in both images, scale bar=250μm.




Figure 3. Panel a: Fiji-software-processed immuohistological 
image of an ablated superior vena cava of pig 6 with tissue 
ink applied (insert) at the endothelial side at the level of the 
heating spot (between two arrows), with the latter identifiable 
as the myosin proteins are almost all denatured at this level, 
scalebar=500μm. Panel b: Detail of panel a with the insert 
indicating the applied ink, scalebar=100μm. Panel c: Higher 
magnification of the insert indicated in panel b with the arrows 
indicating the applied blue tissue ink, scale bar=100μm.
Figure 4. Panel a: Fiji-software-processed immunohistological 
image of an ablated superior vena cava of pig 4 with tissue ink 
applied at the endothelial side at the level of the heating spot, 
indicated by the arrows in panel b, scale bar of panel a=1mm. 
Panel b: Higher magnification of the delimited area in panel 
a, indicating both a non-ablated region (1) and ablated region 
(2), scale bar=100μm. Panel c: Highly enlarged detail of panel 
a, demonstrating an insulating barrier consisting of charred (1) 
and connective tissue (2) between the heating area (indicated 
by the blue ink) and the intact myocardial tissue (3), scale 
bar=100μm.
Figure 5. Both images (a and c) are derived from ablation trials 
with the same setting and conditions. Panel a: Fiji-software-
processed immunohistological image of an ablated pulmonary 
vein of pig 10. The arrow indicates an ablation lesion of 
approximately 2.38 mm, L =lumen, scalebar=1mm. Panel b: 
detail of panel a, indicated by the box, in which the loss of 
staining is visualized, L=lumen, scalebar= 0.5mm.  
Panel c: Fiji-software-processed immunohistological image of 
an ablated pulmonary vein of pig 11. The black arrows indicate 
two ablation spots (0.6mm and 1mm) in myocardial layer 1. 
The white arrows indicate the fat layer between myocardial 
layer 1 and 2, L=lumen, scalebar=1mm. Panel d: detail of panel 
c, indicated by the box, in which the lighter staining visualizes 
the transition of normal tissue to ablated tissue, L=lumen, 
scalebar=0.5mm.
Figure 6. Panel a: Fiji-software-processed immunohistological 
image of an ablated pulmonary vein of pig 12. The section was 
cut parallel to and 10μm from the endothelium. The arrows 
indicate the diamond-shaped ablation lesion which matches 
perfectly the organization of the struts, scale bar=2mm. 
Panel b: detail of panel a, indicated by the box, in which the loss 
of staining is indicated in higher magnification by the double 
arrow, scale bar=0.4mm. Panel c: Fiji-software-processed 
immunohistological image of an ablated pulmonary vein of pig 
13. The section was cut longitudinally and the arrows indicate 
several transmural ablation lesions at regular distances, due to 
the structure of the stent. Scale bar=2mm.at different depths, measured from the endothelium at the 
level of the applied ink. All samples included, the ablation 
depth ranged from 0.45mm to 2.38mm. 
If superficially induced charring and/or physiologic connec- tive tissue was present between themyocardial tissue and the 




heat source, little or no myosin denaturation was observed 
(Figure 4). Often, pulmonary vein samples demonstrated 
several layers of myocardial tissue separated from each other 
by fat and connective tissue. In that case, no myosin dena-
turation was noticed in the myocardial sleeve layer located 
at the adventitial side of the fat whereas at the same level, a 
transmural lesion could be observed in the myocardial tissue 
located at the endothelial side. 
Two samples of pulmonary vein tissue were ablated under 
the same conditions and with the same power setting. The 
sample in which no fat was present demonstrated an ablation 
lesion, more than twice the depth compared to the lesion 
observed in the sample in which the myocardial sleeve layer 
was divided in two by an intermediate layer of fat (Figure 5).
Several immunohistochemical sections of the pulmonary 
veins provided an ablation pattern which is in accordance 
with the structure of the stent. The stent is build-up by a 
number of struts and the diamond-like shape of the struts 
was recognized in the ablated tissue (Figure 6). 
Discussion 
The standard histological staining methods fail to make a 
clear distinction between destructed tissue and intact tis-
sue. Moreover, with these techniques it is sometimes hard to 
visualize objectively the gradual reduction of heat intensity 
when sampling away from the ablation point. A misinterpre-
tation of the grade of heat penetration, based on a regular 
histological staining, could be caused by an unequal fixation 
of the tissue, due to a variable tissue thickness as no control 
is available. Further, regular histological staining methods 
are not directly linked with the process occurring in ablated, 
destructed or denatured tissue but offer an overview of the 
present tissue types without discriminating between heated 
and non-heated tissue. The supra-vital staining with tetra-
zolium is frequently used to distinguish non-vital from vital 
tissue [13]. However, in the case of determining the grade of 
transmurality, more detail or histological images on higher 
magnification are required which is not possible with this 
supra-vital staining. On the other hand, immunohistochemical 
staining with antibody myosin MYBPC3 visualizes exactly the 
gradual denaturation of the muscle protein myosin, which is, 
according to Tornberg (2005) [14], the first characteristic of 
muscle tissue that will be affected during a heating process.
The evaluation of the degree of chronic ablation lesions 
will offer less difficulties as ingrown connective tissue will 
replace destructed cardiac tissue. However, in chronic samples, 
the described immunohistochemical technique will also be 
valuable as it detects viable myocardial tissue. 
The use of a too high or too low temperature during an 
ablation procedure will fail to achieve a transmural lesion. 
The application of extreme temperatures or distribution of 
energy on a small area will lead to superficial endothelial 
charring, which reduces energy transfer to the underlying 
cardiac muscle. On the other hand, myocardial sleeve tissue 
fans out distally, thus heart muscle fibers, covered by fat and 
connective tissue, could get shielded from the ablating heat 
source. Some samples, investigated in this study, demonstrated 
that heat penetration into the venous wall was limited due to 
the insulating effect of connective, fat and/or charred tissue.
This could be a reason why recurrence of ectopic electrical 
conductance is frequently seen after ablation procedures. The 
constitution of the venous wall needs to be considered in 
case of ablation failure, AF recurrence is noticed or electrical 
conductance persists. 
Conclusions 
This study demonstrates an immunohistochemical staining 
technique with the MYBPC3 antibody to visualize and to asses 
objectively acute ablation lesions. Moreover, the importance 
of the insulating role on heat transfer of endothelial charring, 
fat or connective tissue is emphasized.
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